From 825c4cdd2a7d2e71bebb8c3542337186020b6250 Mon Sep 17 00:00:00 2001
From: Will King <will.king.git@youainti.com>
Date: Thu, 7 Nov 2024 10:46:41 -0800
Subject: [PATCH] minor adjustment to outline2

---
 Latex/Paper/outline2.txt | 3 ++-
 1 file changed, 2 insertions(+), 1 deletion(-)

diff --git a/Latex/Paper/outline2.txt b/Latex/Paper/outline2.txt
index 562df84..835ab00 100644
--- a/Latex/Paper/outline2.txt
+++ b/Latex/Paper/outline2.txt
@@ -25,7 +25,8 @@ Hyrimoz, Idacio, Simlandi, Yuflyma, and Yusimry),
 the biosimilars are required to prove they have similar efficacy and safety to the
 reference drug.
 
-When registering these clinical trials
+When registering a clinical trial,
+the investigators are required to 
 % discuss how these are registered and what data is published.
 % Include image and discuss stages
 % Discuss challenges faced